: - - - - ( ) ( )
, October 2011, Sharma, Shruti et al
Aon | Professional Services Practice Weight Loss Drugs: A Point of View for Professional Service Firms in the U.S., UK, and Canada A drug class known as GLP-1 receptor agonists or simply GLP-1s (e.g., Novo Nordisks Ozempic) has been used for several years to help control type 2 diabetes
Drawing on FDA signals, past regulatory precedent with Orlistat, recent pricing negotiations, softened safety language, and public comments from pharmaceutical executives, Dave lays out the case that low-dose oral GLP-1s could be the first step toward OTC access
Consumers can verify pharmacy listings using our generic semaglutide tracker, review plan eligibility through the insurance coverage checker, or consult the FAQ